Hoghoughi, Mohammad Ali
Jouybar, Reza
Alvandi, Akbar
Shahriarirad, Reza
Hosseinpour, Hamidreza
Ranjbar, Keivan
Kamran, Hooman
Article History
Received: 2 February 2023
Accepted: 22 August 2023
First Online: 5 September 2023
Declarations
:
: The study was approved by the ethics committee of Shiraz University of Medical Sciences (IR.SUMS.MED.REC.1398.395), the Institutional Review Board, and the Iranian Registry of Clinical Trials (IRCT20200907048652N2) on 2/1/2021. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.
: Informed consent was obtained from all patients or their legally authorized representatives for being included in the study.
: Informed consent was obtained from all patients or their legally authorized representatives for the publication of the study.
: Mohammad Ali Hoghoughi, Reza Jouybar, Akbar Alvandi, Reza Shahriarirad, Hamidreza Hosseinpour, Keivan Ranjbar, and Hooman Kamran declare no competing interests.